Pristimerin exerts antitumor activity against MDA-MB-231 triple-negative breast cancer cells by reversing of epithelial-mesenchymal transition via downregulation of integrin β3

BACKGROUND: Pristimerin, a natural flavonoid compound, has potential anti-tumor activities. These activities have been illustrated in various cancer cell lines, including MDA-MB-231 cells. MDA-MB-231 cells are a representative mesenchymal subtype of triple negative breast cancer (MES-TNBC) cell line...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Shiyue, Dong, Youhong, Wang, Ying, Hu, Pengchao, Wang, Jing, Wang, Robert YL.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Chang Gung University 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9038948/
https://www.ncbi.nlm.nih.gov/pubmed/35652598
http://dx.doi.org/10.1016/j.bj.2020.07.004

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9038948/
https://www.ncbi.nlm.nih.gov/pubmed/35652598
http://dx.doi.org/10.1016/j.bj.2020.07.004

Ejemplares similares